drug

Telmisartan

MeSH D000077333
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Massachusetts, Worcester
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
NCT00981526Phase 4Completed

KOLs & investigators

1
Xiaoduo Fan, MD, MPH, MSKOL score 9

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Massachusetts, Worcester
company
trial
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Xiaoduo Fan, MD, MPH, MS
KOL score 9
person